Final Call for BIO San Francisco Investor Forum Advance On-line Media Registration

WASHINGTON, D.C. (September 27, 2004) -- Advance online media registration for the Biotechnology Industry Organization’s (BIO) BIO Emerging Company Investor Forum, to take place October 13-15 at the Palace Hotel in San Francisco, closes Wednesday, October 6, 2004.

Registration is complimentary for credentialed news media.  Advance registration is required for all freelance journalists, college and online publications.  To register, please visit www.bio.org. 

Only reporters working full-time for print or broadcast news organizations with valid media credentials may register onsite.

The BIO Emerging Company Investor Forum will present over 200 emerging private and public product and technology focused companies and showcase a series of therapeutic and technology workshops, business roundtables, and topical plenary sessions led by the industry’s leading practitioners and thought leaders. 

Samples of roundtable discussions and workshops include: Novel Cardiovascular Drugs from the Biotechnology Industry; Business Strategy in the Era of Personalized Medicine; Why Should VCs Invest in Early Stage Companies; The Future of Obesity Therapy:  Diet?  Drugs?  Devices? ; and Managing AIDS for Long Term Survival: Treatments on the Horizon.

An updated schedule of programming for the event is available online at www.bio.org/events/. 

BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products.

###